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XPD Mutations Prevent TFIIH-Dependent
Transactivation by Nuclear Receptors
and Phosphorylation of RAR
viating nucleosomal repression through remodeling
chromatin structure is thus a prerequisite for gene ex-
pression (Dilworth and Chambon, 2001). Nuclear recep-
tors contribute to this function, upon binding the cog-
nate ligand and specific DNA sequences, either by
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zymes, or by targeting components of the transcriptionFrance
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they could allow regulation of one or more of the enzy-UPR 2169 CNRS
matic activities that govern transcription: either the syn-B.P.8, 94801 Villejuif Cedex
thesis of RNA, or the promoter opening and/or the phos-France
phorylation of components of the gene expression
apparatus. Alternatively, activation of transcription by
nuclear receptors might depend upon components thatSummary
are associated with or part of the basal transcription
machinery. Indeed, several nuclear receptors wereInherited mutations in the XPD subunit of the general
found to be phosphorylated at different positions bytranscription/repair factor TFIIH yield the rare genetic
several kinases including the MAP-kinase (Kato et al.,disorder Xeroderma pigmentosum (XP), the pheno-
1995), the protein kinase A (Rochette-Egly et al., 1995;types of which cannot be explained solely on the basis
Chen et al., 1999), the protein kinase C (Delmotte et al.,of a DNA repair defect. In cells derived from XP-D
1999), as well as the cyclin-dependent kinase cdk7, onepatients, we observed a reduction of the ligand-depen-
of the subunits of the basal transcription factor TFIIHdent transactivation mediated by several nuclear re-
(Keriel and Egly, 2001 and references therein).ceptors (RAR, ER, and AR). We demonstrate that
TFIIH is a candidate for mediating transcription activa-the XPD mutation alters cdk7 function in RAR phos-
tion because it possesses most of the enzymatic activi-phorylation. Transactivation is restored upon overex-
ties that are essential for RNA synthesis. This multipro-pression of either the wild-type XPD or the RARS77E
tein complex, also involved in the nucleotide excision(a mutation which mimics phosphorylated RAR).
repair (NER; de Boer and Hoeijmakers, 2000) pathwayThus, we demonstrate that the cdk7 kinase of TFIIH
and composed of nine subunits, can be resolved in twophosphorylates the nuclear receptor, then allowing
subcomplexes: the core-TFIIH, containing the XPB, p62,ligand-dependent control of the activation of the hor-
p52, p44, and p34 subunits, and the cdk-activating ki-mone-responsive genes.
nase (CAK) complex containing cdk7, cyclin H, and
MAT1 (Roy et al., 1994; Serizawa et al., 1995; ShiekhattarIntroduction
et al., 1995). The remaining XPD subunit can be found
associated either with the core-TFIIH or with CAK (Drap-It has long been established that hormones control nu-
kin et al., 1996; Reardon et al., 1996; Rossignol et al.,merous physiological events in vertebrate development,
1997) and bridges both subcomplexes (Coin et al., 1999).growth, reproduction, and cell differentiation by regulat-
The XPB and XPD helicases catalyze DNA opening, ei-ing expression of specific networks of genes. These
ther around the transcription initiation site or around a
molecules exert their pleiotropic effects through specific
DNA lesion (Holstege et al., 1996; Evans et al., 1997).
nuclear receptors, such as receptors for retinoids (RAR
The cdk7 kinase uses several substrates such as the
and RXR), vitamin D (VDR), steroid (ER, AR, GR), and carboxy-terminal domain (CTD) of the largest subunit of
thyroid hormones (TR), which act as transcription activa- RNA pol II, which most likely further modulates several
tors. Much is known concerning nuclear receptors which RNA processing activities (McCracken et al., 1997 and
exhibit a conserved modular organization including a references therein). In addition, TFIIH targets and phos-
central DNA-binding domain (DBD), a ligand-binding do- phorylates (at least in vitro) several transcriptional acti-
main (LBD), a dimerization domain, and two transcrip- vators including the nuclear receptors RAR, RAR, and
tional activation functions, AF-1 and AF-2 (Chambon, ER (Rochette-Egly et al., 1997; Bastien et al., 2000;
1996; Dilworth and Chambon, 2001). However, the mo- Chen et al., 2000).
lecular mechanisms that allow the hormonal signal to be Another interesting feature, at the origin of the present
transduced from the receptors to the basal transcription work, came from observations involving certain patients
machinery and, more precisely, how they become acti- carrying a mutation in XPD and suffering from Xero-
vated in the cell remains to be established. derma pigmentosum (XP), a genetic disorder very often
Basal transcription is a multistep process directed by associated with Cockayne syndrome (CS) or Trichothio-
six basal transcription factors (TFIIA, B, D, E, F, and H) dystrophy (TTD) and primarily defined as a DNA repair
and RNA polymerase II (RNA pol II), the access to the syndrome (van Steeg and Kraemer, 1999). XP is indeed
DNA template being restricted by the nucleosomes. Alle- characterized by a deficiency of the NER pathway and
patients exhibit high photosensitivity of the skin follow-
ing sun exposure, driving in some cases to multistage3 Correspondence: egly@igbmc.u-strasbg.fr
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carcinogenesis, including melanomas, squamous cell We then tested the transactivation capacity of the
carcinomas, and basal cell carcinomas (Kraemer et al., estrogen (ER) and the androgen (AR; Lee et al., 2000)
1988). They also exhibit a large spectrum of clinical ab- nuclear receptors by using pERE-Luc (Figure 1A) and
normalities such as mental retardation, immature sexual pARE-CAT reporters (cf. Experimental Procedures). In con-
development, skeletal abnormalities, and dwarfism (de trast to RAR, ER, and AR are not expressed endoge-
Boer and Hoeijmakers, 2000), some of which could be nously in HeLa and HD2 cells. We thus cotransfected
connected with hormonal dysfunctions. Moreover, reti- both cell lines with either the pERE-Luc or pARE-CAT
noic acid, already used as a chemopreventive agent for reporter and either of the expression vector pcDNA-
the treatment of several types of cancer (reviewed in ER, pSV-ARo, or the corresponding empty vectors, and
Niles, 2000), was rather successful to decrease carcino- pCH110. Both receptors were similarly overexpressed in
genesis susceptibility in XP patients (Kraemer et al., HeLa and HD2 cells as shown by Western blotting (Fig-
1988). ures 1C and 1D, upper panels). Cells were subsequently
In the present study, we demonstrate that mutations treated with 108 M of either 17-estradiol (E2) or 5-
in the xpd gene result in a drop in the ability of nuclear dihydrotestosterone (DHT). In HeLa cells, reporter gene
receptors to be phosphorylated by TFIIH and to stimu- activities were stimulated by ER (10-fold) and AR (50-
late expression of the target genes. We show that this fold), respectively, upon addition of their corresponding
defect can be circumvented upon overexpression of ligands (Figures 1C and 1D, dark boxes). In contrast,
either the wild-type XPD or the RARS77E form of RAR, transactivation observed in HD2 cells was 4–5-fold lower
in which the glutamic acid mimics a phosphorylated than in HeLa cells (hatched boxes). Control experiments
serine residue. Together, our data strongly enlighten show the specificity of the reporter gene activation,
the key role of TFIIH in the transcriptional activation which requires the presence of both the nuclear receptor
mediated by hormonal receptors and illustrate how and its cognate ligand. Finally, we also tested the ability
some phenotypes of XPD patients could find explana- of the chimeric protein Gal4-VP16 (GVP16) to mediate
tion in a defect of one of the other enzymatic functions transcription activation in HD2 cells. HeLa and HD2 cells
of this complex. were cotransfected by the reporter construct pGal-Luc,
in which four Gal4 binding sites control expression of
Results the Luc gene, the eukaryotic expression vector pSG5-
GVP16, or the corresponding empty vector. In both cells,
XPD Mutation Prevents Nuclear Receptor- GVP16 significantly stimulates expression of the re-
Mediated Activation of Transcription porter gene (Figure 1E), demonstrating that the tran-
Because mutations in the XPD subunit of TFIIH can lead scriptional regulation defect in HD2 cells is restricted to
to pathologies with complex phenotypes, some of which certain activators.
cannot be explained on the basis of NER defects alone, Altogether, these data highlight a reduced ligand-
we wondered if such mutation(s) could alter expression dependent activation of transcription by three nuclear
of genes that are under the control of nuclear receptor receptors, RAR, ER, and AR, in cells bearing a muta-
response elements. We thus monitored ligand-depen- tion in the XPD subunit of the basal transcription/repair
dent activation of a reporter gene in the HD2 cell line factor TFIIH. They also suggest that regulation of the
that carries the point mutation R683W in XPD. expression of hormone-responsive genes so far tested
A DR5-type retinoic acid response element (RARE), involves a common mechanism that is not related to
specifically recognized by RAR/RXR heterodimers (Dil- some cellular specialization but that rather depends on
worth et al., 2000), was cloned in front of the luciferase
the integrity of TFIIH.
reporter gene resulting in the pRARE-Luc reporter con-
struct (Figure 1A). Since HD2 cells result from the hybrid-
Defect in Transactivation Is Circumventedization between human fibroblasts (carring the mutation
upon wtXPD Overexpressionin the xpd gene) and HeLa cells (Johnson et al., 1985), the
We then wondered whether the defect in transactivationcellular response to retinoic acid (t-RA) was monitored in
by the nuclear receptors observed in HD2 cells, wasHD2 cells and HeLa cells, as well as in wild-type MRC5
due to the mutation in the xpd gene itself. HD2 and HeLafibroblasts. HD2, HeLa, and MRC5 cells, which contain
cells were thus cotransfected by either pRARE-Luc orequivalent amounts of endogenous RAR, RXR, and
pARE-CAT in addition to either pcDNA-XPD, encodingTFIIH proteins, as established by immunoblotting on
the wild-type XPD (wtXPD), or the corresponding emptycrude cell extracts (Figure 1B, left panel), were cotrans-
vector, and were harvested 48 hr posttransfection tofected with pRARE-Luc and the -galactosidase encod-
allow adequate expression (visualized by Western blot-ing plasmid pCH110, as an internal control. Cells were
ting; data not shown) and incorporation of wtXPD intosubsequently treated with increasing concentrations of
the TFIIH complex (Winkler et al., 1998). Overexpressiont-RA for 24 hr before monitoring the luciferase and
of wtXPD in HD2 cells restores transcriptional activation-galactosidase activities. In HeLa and MRC5 cells, t-RA
of the reporter genes upon ligand addition, whereas ittreatment results in a stimulation of the reporter gene
does not significantly modify synthesis of the reportertranscription with a peak of about 5-fold activation at
products in HeLa cells (Figures 2A and 2B, compare106 M t-RA (Figure 1B, dark and clear boxes), where
lanes 2 to lanes 1). This correction was specific to theafter increasing the t-RA concentration inhibits tran-
wtXPD protein since neither cotransfection with thescription activation. In contrast, the t-RA response ob-
same amount of the corresponding empty vector (lanesserved in the HD2 cells is about half of that observed
in the two wild-type cell lines (Figure 1B, hatched boxes). 3) nor overexpression of two unrelated proteins (p53 and
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Figure 1. Transactivation of Transcription Is Defective in XP-D Cells
(A) Schematic representation of the pRARE-Luc and pERE-Luc reporter constructs. The luciferase reporter gene is placed under the control
the SV40 promoter and either a DR5-type retinoic acid response element (RARE) or a PAL3-type estrogen response element (ERE). The core
binding motifs of the response elements are indicated by arrows. Ampr : ampicilin resistance gene.
(B) Western blotting analysis of endogenous TFIIH, RAR, and RXR in HeLa and HD2 crude extracts using -tubulin (-tub) as internal
control. HeLa (dark boxes), HD2 (hatched boxes), and MRC5 (clear boxes) cells were transfected with pRARE-Luc (1 g) and pCH110 (-gal;
1 g) and subsequently treated with 108 to 105 M all-trans retinoic acid (t-RA).
In (C), (D), and (E), HeLa (dark boxes) and HD2 (hatched boxes) cells were cotransfected with either pERE-Luc (1 g), pARE-CAT (1 g), or
pGal-Luc (1 g) reporter plasmids, in addition to pCH110 (1 g) and either pcDNA-ER (100 ng), pSV-ARo (500 ng), pSG5-GVP16 (500 ng)
expression vectors or the corresponding empty vectors, and subsequently treated with 108 M of 17-estradiol (E2) or 108 M of
5-dihydrotestosterone (DHT), as indicated at the top of each panel. Transactivation of the reporter genes was measured by monitoring in
parallel both the luciferase (or the CAT) and the -galactosidase activities. The results are the mean of at least four independent experiments.
Western blotting indicates the amount of the overexpressed ER, AR, and Gal4-VP16 in the two cell lines.
E2F1; data not shown) had any effect on the regulation of encoding the XPD subunit of the general transcription
factor TFIIH.transcription mediated by RA in this XPD-deficient cell
line.
In a parallel set of assays, HeLa and HD2 cells were XPD Mutation Does Not Affect Basal Transcription
Since XPD is part of a general transcription factor, onetransfected with the pRARE-EGFP reporter plasmid in
which the Luc gene was replaced by the gene coding could imagine that the drop in transcription activation
observed in HD2 cells might simply be due to a defectfor the enhanced green fluorescent protein (EGFP). After
incubation with 106 M t-RA, living cells were observed in basal transcription. TFIIH complexes immunopurified
at low-salt concentration (Figure 3B, lanes 1 and 2),under UV. As expected, EGFP fluorescence is signifi-
cantly increased by t-RA treatment in HeLa cells (Figure were thus tested in a reconstituted in vitro transcription
system including only the basal transcription factors2C, compare panels a and b); neither cotransfection with
pcDNA-XPD (panel c) nor with the empty vector (panel and RNA pol II (Gerard et al., 1991). Both TFIIHs were
able to synthesize a 309 nt run-off transcript from thed) altered this stimulation. In HD2 cells, the t-RA re-
sponse is restored upon overexpression of wtXPD, as AdML promoter (Figure 3A). Similarly, HD2 and HeLa
whole-cell extracts exhibited equivalent basal transcrip-shown by a much higher EGFP expression (compare
panels e and h). tion activities (data not shown). Moreover, RT-PCR
shows that expression of the -actin gene, commonlyThe above results clearly demonstrate that the weak
responses to retinoic acid and androgen hormones ob- used to monitor the basal transcription activity, is not
altered in the HD2 cells (data not shown). Altogether,served in HD2 cells is due to the mutation in the gene
Cell
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Figure 2. Hormonal Response Is Restored in XP-D Cells upon wtXPD Overexpression
HeLa (dark boxes) and HD2 (hatched boxes) cells were cotransfected with 1 g of either pRARE-Luc (A) or pARE-CAT (B), 1 g of pCH110,
and 100 ng of either pcDNA-XPD or empty pcDNA and subsequently treated with 106 M t-RA or 108 M DHT, respectively. The relative
luciferase and CAT activities were calculated as described in Figure 1 and the values are indicated as percentages, 100% being the level of
transactivation obtained in Hela cells.
(C) HeLa and HD2 cells were cotransfected with pRARE-EGFP (1 g), pCH110 (1 g), and either pcDNA-XPD (100 ng) or empty pcDNA (100
ng) as indicated, and subsequently treated with 106 M of t-RA. EGFP fluorescence was visualized using an inverted phase microscope.
these observations allow us to extrapolate the conclu- contains all nine subunits in “physiological” conditions,
the mutation in XPD weakens anchoring of the kinasesion that the defect of transcription activation observed
in vivo is not linked to the basal transcription activity (CAK) subcomplex to the core-TFIIH.
Knowing that the cdk7 kinase phosphorylates nuclearof HD2-TFIIH but, rather, to a distinct function of the
complex in the transcription process. receptors in vitro, we then questioned whether the XPD
mutation might alter this process. We therefore investi-
gated the in vivo phosphorylation state of RAR in XPD-XPD Mutation Is Responsible for RAR
deficient cells. Substantial amounts of HeLa or HD2 cellsUnderphosphorylation in HD2 Cells
were incubated with radiolabeled orthophosphate and,We then wondered whether the R683W mutation could
after concentration adjustment by Western blotting, im-affect the integrity of the TFIIH complex. Indeed, previ-
munoprecipitated RAR fraction from both extractsous studies have shown that the XPD subunit anchors
were subjected to autoradiography (Figure 4A). We ob-the CAK subcomplex to the core-TFIIH (Drapkin et al.,
served that RAR extracted from HD2 cells is signifi-1996; Reardon et al., 1996; Coin et al., 1999). Moreover,
cantly underphosphorylated (around 50%) compared tomutations in the carboxy-terminal end of XPD weaken
that from HeLa cells. We then wondered whether in vivoits binding to the p44 subunit of the core-TFIIH (Coin et
underphosphorylation of RAR was due to a lack ofal., 1998). TFIIH complexes were thus immunopurified
phosphorylation by the kinase of TFIIH. We thus testedfrom HeLa or HD2 cells at either low-salt (50 mM KCl)
the ability of HD2-TFIIH, immunopurified at low-salt con-or high-salt (400 mM KCl) concentration. When immuno-
centration (Figure 3B, lane 2), to phosphorylate in vitropurification was performed at high stringency, we ob-
a bacterially expressed RAR on its serine 77, a site ofserved that the XPD and the CAK subunits unhooked
phosphorylation that is crucial for the transactivatingfrom other TFIIH subunits in HD2 cells whereas HeLa-
activity of RAR (Rochette-Egly et al., 1997). Using aTFIIH was intact (Figure 3B, compare lanes 2 and 4). This
observation shows that, in HD2 cells, although TFIIH monoclonal antibody specific for RAR phosphorylated at
XPD Mutation Prevents Transactivation by NRs
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phosphorylation by TFIIH and to promote ligand-depen-
dent activation of transcription (Rochette-Egly et al.,
1997). We thus overexpressed various forms of RAR
in which S77 was substituted either by an alanine (RAR-
S77A) or by a glutamic acid (RARS77E), which mimics
a constitutively phosphorylated S77 residue. In both Cos
and HeLa cells, RARS77E mediates transactivation as
well as the wild-type protein (our unpublished results).
In HD2 cells, neither RARwt nor RARS77A are able to
stimulate the reporter gene expression (Figure 6, lanes
6 and 7), whereas overexpression of RARS77E circum-
vents the XPD mutation defect and allows transactiva-
tion to a similar level as that observed in HeLa cells
(compare lane 5 to lane 2). Furthermore, ligand require-
ment, even in the presence of the artificially phos-
phorylated RAR (lane 8), shows unambiguously that
phosphorylation is necessary but not sufficient for trans-
activation.
These results demonstrate that overexpression of the
“constitutively” phosphorylated RAR (RARS77E) sub-
stitutes for the defect resulting from the XPD mutation
in HD2 cells. In addition, they provide evidence that the
defect in ligand-dependent activation is most likely due
to the inability of the cdk7 kinase to efficiently phosphor-
ylate RAR on its S77 residue.
RA-Transactivation Deficiency Is Not Restricted
to the R683W Mutation in XPDFigure 3. Mutation in XPD Does Not Alter the Basal Transcription
Activity of TFIIH We finally wondered whether other cell lines, carrying
a different xpd allele, would also be associated with(A) Immunopurified TFIIH from either HeLa or HD2 cells at low-salt
concentration, were tested in a reconstituted in vitro transcription compromised hormone-mediated transcription regula-
assay using the AdMPL as a template (allowing synthesis of a 309 tion. We thus monitored transcription activation in two
nt transcript). Positive and negative controls were performed in the immortalized fibroblast cell lines, XP6BE-X and TTD1VI-X
presence or absence of highly purified TFIIH (Gerard et al., 1991).
(containing the EBV-based p205-KMT11 plasmid; Stary(B) Western blot analysis of HeLa- or HD2-TFIIH immunopurified
et al., 1992) and representing most of the XPD patientsTFIIH at low-salt (LS, 50 mM KCl) or high-salt (HS, 400 mM KCl)
identified to date. These cells bear the XPD mutation atconcentration.
positions R683W and R722W, respectively; these muta-
tions weaken the interaction of XPD with the p44 subunit
of TFIIH (Coin et al., 1998). The TTD1Br fibroblast, de-position S77 (RAR-P-S77), we clearly show that HD2-TFIIH
rived from a TTD patient of the TTD-A complementationbarely phosphorylates RAR (Figure 4B). In contrast,
group, does not carry any mutation in the genes encod-HD2-TFIIH normally phosphorylates the carboxy-termi-
ing the subunits of TFIIH, and is characterized by anal domain (CTD) of RNA pol II (Figure 4C), a phosphory-
sublimiting amount of TFIIH which affects its DNA repairlation event required at various stages of transcription
function in response to genotoxic stress (Vermeulen etinitiation (Lu et al., 1992; Dahmus, 1996), demonstrating
al., 2000). These three cell lines contain equivalentthat the enzymatic activity of cdk7 is not altered and
amounts of RAR and RXR proteins (Figure 7A).that the kinase is able to discriminate between the two
Whereas in the wild-type MRC5 fibroblasts, t-RA treat-substrates.
ment stimulates efficient expression of the reporterWe then investigated the in vivo phosphorylation of
gene, only a weak stimulation occurs in the two XPD-RAR in the corrected HD2 cells (upon transfection with
deficient cells in which expression of the reporter genepcDNA-XPD). Overexpression of wtXPD in HD2 cells
is reduced about 55%–65% (Figure 7B), which is compa-restores the endogenous RAR phosphorylation to the
rable to what was observed in HD2 cells (Figure 1B). Innormal level (Figure 5, compare lanes 2 and 3), demon-
contrast, TTD1Br cells respond normally to t-RA.strating in an unequivocal fashion the direct link between
Thus, our preliminary results seem to indicate thatthe alteration of the XPD protein and the defect in RAR
C-ter mutations altering p44/XPD interaction also alterphosphorylation.
the function of TFIIH in the transcription regulation medi-
ated by RA.RAR Hypophosphorylation Is Responsible
for Reduced Transactivation In Vivo
We then investigated whether there was a direct link Discussion
between the defect in the ability of TFIIH to phosphory-
late RAR and the poor response to t-RA observed in In the course of our investigations to understand mecha-
nisms of gene expression, we have focused on the roleHD2 cells, knowing that the serine 77 of RAR (AF-1
domain) was suggested to be the main target sites for of the various enzymatic activities of TFIIH, a multisub-
Cell
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Figure 4. RAR Is Underphosphorylated in
XP-D Cells
(A) In vivo phosphorylation of RAR was in-
vestigated in Hela and HD2 cells upon immu-
noprecipitation, Western blotting (WB, RAR),
and autoradiography (Autoradio, 32P-RAR).
Quantitative analysis of RAR phosphoryla-
tion in HeLa and HD2 cells represents the
ratio autoradiographic/Western blot signals
and were set up to 100% for HeLa cells. IgH
and IgL: heavy and light chains of immuno-
globulins.
(B) Bacterially expressed RAR was phos-
phorylated in vitro by HeLa- or HD2-TFIIH,
immunopurified at low salt, and analyzed by
Western blotting using antibodies specific for
its F region (RP(F)) or the phosphorylated
serine 77 (RAR-P-S77).
(C) The RNA pol II kinase activity of low salt
immunopurifed TFIIH was analyzed in an in
vitro assay containing all the basal transcrip-
tion factors and the AdMLP (Tirode et al.,
1999). Hypo (IIA) and hyperphosphorylated
(IIO) forms of RNA pol II largest subunit were
revealed by Western blotting using an anti-
body that recognizes an evolutionarily con-
served epitope inside the CTD.
unit complex involved in both transcription and DNA ing that there is a common mechanism that links TFIIH
to the transactivation mediated by several nuclear re-repair. These studies have been helped by the finding
that mutations in the XPB and XPD helicases of TFIIH are ceptors. At this stage, it is interesting to note the clinical
study performed on XP patients, bearing alterations inat the origin of Xeroderma pigmentosum (XP; Lehmann,
2001). Some of the clinical features of XP, such as UV one of the genes involved in the NER pathway. Treating
these patients with a high-dose of oral retinoids reducessensitivity and high skin cancer susceptibility, can easily
find explanations in a faulty DNA repair due to a defect the frequency of development of new skin cancers
(Kraemer et al., 1988). There is however an exception:of these helicases to open DNA around a lesion (Evans
et al., 1997; Lehmann, 2001). However, the essential an XP patient, carrying the R683W mutation in XPD,
role of XPB in transcription is also responsible for the
severity of the phenotypes as well as the restricted num-
ber of XP-B patients so far identified (Guzder et al.,
1994). Therefore, even if analysis of the XP-D patient’s
phenotypes, varying from neurological abnormalities to
growth retardation, pleads for a defect in gene expres-
sion, the role of XPD in transcription is still not fully
understood.
Although we did not associate the helicase function
of XPD with a transcription defect of TFIIH, we show
here how XPD provides support for CAK action and, as
such, plays an important structural function. We demon-
strate that TFIIH is an indispensable component of the
hormonal response in vivo through its cdk7 subunit that
phosphorylates nuclear receptors, allowing further trans-
activation of their target genes.
Hormone-Mediated Regulation of Transcription
Requires Intact TFIIH
When transfected in cells carring a mutation in the XPD
subunit of TFIIH, expression of the reporter genes
placed under the control of RAR, ER, and AR is af-
fected, whereas Gal4-VP16 activation occurs normally.
One can imagine that the stronger magnitude of trans-
activation alteration by the exogenous receptors ER Figure 5. RAR Phosphorylation Is Restored in wtXPD-Corrected
and AR is due to the overexpression of these proteins, HD2 Cells
that had to fullfill the entire expression and phosphoryla- In vivo phosphorylation of RAR was investigated in Hela and
tion processes before gene targeting. Overexpression pcDNA-XPD transfected HD2 cells (as indicated at the top of the
panel) as in Figure 4A.of wtXPD in these cells restores transactivation, show-
XPD Mutation Prevents Transactivation by NRs
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Figure 6. RARS77E Restores Transactiva-
tion in XP-D Cells
HeLa (dark boxes) and HD2 (hatched boxes)
cells were cotransfected with pRARE-Luc (1
g), pCH110 (1 g), and 100 ng of either
pSG5-RARS77E, pSG5-RARWT, pSG5-
RARS77A, or pSG5, and subsequently
treated with 106 M t-RA for 24 hr. The lucifer-
ase reporter gene activity was measured as
before.
although developing the typical retinoid related toxici- poor in vitro phosphorylation of RAR by the XPD-defi-
cient TFIIH could be due to an incorrect positioningties, did not respond to this therapy as well as the other
XP patients (K.H. Kraemer, J.J. DiGiovanna and T. Ueda, of the kinase relative to its substrate. Our results also
suggest that, even if free CAK is able to phosphorylatepersonal communication).
Our study raised questions concerning the role of RAR in vitro (Rochette-Egly et al., 1997), in vivo phos-
phorylation is carried out only by TFIIH. Indeed, freeTFIIH in the hormonal response. It was tempting to attri-
bute the weak transactivation observed in XP-D cells to CAK is not able to substitute for TFIIH for the nuclear
receptor phosphorylation in XPD-deficient cells. It isa defect in some of the enzymatic activities of TFIIH
which are directly involved in RNA synthesis. We demon- worth mentioning that the residual phosphorylation of
RAR observed in the XP-D cells (and that most likelystrate here that a C-terminal mutation, identified in an
XP-D patient, does not affect the basal transcription concerns the F domain), may be performed either by
TFIIH (and is thus not affected by XPD mutation), or byactivity of TFIIH. This was not surprising since altering
the enzymatic activity of XPD, by mutating either its ATP a distinct kinase such as the MAP-kinase (Rochette-
Egly et al., 1997).binding site or one of the helicase motifs, does not alter
basal transcription (Tirode et al., 1999; Winkler et al.,
2000) and does not result in lethality (Sung et al., 1988). What Is the Role of Nuclear Receptor
Phosphorylation in Transactivation?However, targeted disruption of xpd in the mouse leads
to preimplantation lethality (de Boer et al., 1998), sug- Phosphorylation of nuclear receptors is necessary but
not sufficient for transactivation, which occurs only ingesting that transcription requires the physical presence
of XPD rather than its helicase activity. Indeed, we dem- the presence of ligand (Dilworth et al., 2000). Indeed,
overexpression of RARS77E, which mimics phosphor-onstrate that the R683W mutation in XPD, which on the
one hand causes an NER defect (Taylor et al., 1997), ylated RAR, has no effect on transactivation unless
ligand is added (Figure 6). Moreover, it seems unlikelyresults on the other hand in a destabilization of the TFIIH
complex and, more precisely, a weakening of the CAK that phosphorylation would influence either ligand bind-
ing or receptor dimerization since these events do notsubcomplex anchoring to the core TFIIH.
require the presence of AF-1 (Bourguet et al., 2000).
Although one cannot exclude that AF-1 phosphorylationRAR Phosphorylation Is a Prerequisite
for Transactivation In Vivo might regulate DNA binding, we observed that in vitro
phosphorylation of RAR occurs even in the absenceIn view of our results, we suggest that the XPD mutation
indirectly affects the specific activity of TFIIH kinase for of its RARE response element (Figure 4B). Alternatively,
phosphorylation of the nuclear receptor could also helpnuclear receptors. Indeed, XPD-deficient cells in which
transactivation is reduced, contain an underphosphory- corepressor release and/or coactivator recruitment and
thus would be implicated in chromatin remodeling (Dil-lated RAR. Reintroducing either RARS77E, which mim-
ics the constitutively phosphorylated S77, or wtXPD, worth et al., 2000). In this respect, it was already demon-
strated that phosphorylations regulate the interactionswhich allows both the formation of active TFIIH (Winkler
et al., 2000) and optimal RAR phosphorylation, restore between coactivators and the AF-1 domain of either
ER or SF-1 (Hammer et al., 1999; Tremblay et al., 1999).transactivation to the normal level. This demonstrates
the in vivo requirement for the nuclear receptor phos- The present data suggest that nuclear receptor phos-
phorylation might occur during the formation of the pre-phorylation by the kinase of TFIIH in the hormonal re-
sponse. Since XPD bridges CAK to the core-TFIIH, the initiation complex, at the time when TFIIH and the nu-
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Figure 7. RA Transactivation Is Defective in XPD-Deficient Fibroblasts
(A) Western blot analysis of TFIIH, RAR, RXR, and -tubulin on MRC5, XP6BE-X, TTD1VI-X, and TTD1Br crude cell extracts.
(B) MRC5, XP6BE-X, TTD1VI-X, and TTD1Br fibroblasts were transfected with pRARE-Luc (2 g) and pCH110 (1 g) and subsequently treated
with 106 M t-RA. Transactivation of the reporter gene was measured as described earlier. The histogram represents [with/without t-RA] ratios.
The results are the mean of at least four independent experiments. The position of the mutation in the xpd gene are indicated.
clear receptor are bound to the promoter and the patients. Indeed, we show the effect of C-terminal muta-
tions in XPD on the function of TFIIH as a mediator ofresponsive element, respectively. In this case, the cdk7
transactivation following hormonal induction. On thekinase, either on its own or together with additional
one hand, XPD mutations weaken its interaction with itsregulatory factors, would phosphorylate RNA pol II and
regulatory subunit p44, thus explaining the DNA repairthe nuclear receptor. Although CTD phosphorylation
defect (Coin et al., 1998; our unpublished data). On thewas suggested to be involved in promoter escape and
other hand, they prevent the phosphorylation of nuclearnuclear receptor phosphorylation in transactivation, at
receptors, subsequently altering their ability to regulatethe present stage of our investigation, it is difficult to
expression of genes that control cell life and develop-connect these two events. Having at hand an in vitro
ment. Indeed, a loss-of-function of the Drosophila cdk7activated transcription system, we failed to produce the
gene induces severe developmental defects and larvalunphosphorylated RAR/RXR heterodimers in E.coli with
lethality (Leclerc et al., 2000; Larochelle et al., 1998). It isthe aim of monitoring their activity upon phosphorylation
also worth mentioning that experiments using genome-by TFIIH. Besides, we observed that a defect in activator
wide expression analysis, revealed that Kin28, the yeastphosphorylation still allows CTD phosphorylation in vitro
cdk7 counterpart, is required for the expression of most(Figure 4C). In contrast with RAR, in vitro phosphoryla-
protein encoding genes (Valay et al., 1995; Holstege ettion of RNA pol II requires the presence of all the compo-
al., 1998).nents of the basal transcription machinery, a conforma-
A major concern is how the position of XPD mutationtional environment that does not seem to be altered by
relates to the clinical features of XP, XP/CS, or TTD.the XPD mutation.
Investigating whether the nature and the position of theBeside its role in transactivation, it is also possible that
amino acid change found in XPD would differentiallyphosphorylation of nuclear receptors might be related to
affect the expression of target genes was rendered diffi-other mechanisms. Indeed, ligand-dependent protea-
cult. First, most of the XPD-deficient cells are heterozy-some-mediated degradation of ER, RAR, and RAR
gotes for xpd alleles. Second, the availability of XPD-was shown to require phosphorylation of AF1 (Nawaz
deficient cells that can be transfected with a satisfyinget al., 1999; Kopf et al., 2000) and could be connected
efficiency (as well as different cell types) is limited. Weto transactivation (Lonard et al., 2000). This proteolytic
nevertheless have monitored RA transactivation in twodegradation by the ubiquitin-dependent pathway could
immortalized fibroblasts derived from XPD-deficient pa-be one of the steps that orchestrate the transcription
tients, in which the causative mutations in xpd are identi-reaction. Proteolysis of the response element-bound ac-
fied (Taylor et al., 1997). These two cell lines carry thetivator is indeed a way of dissociating the engaged RNA
two most frequent XPD C-ter alterations (R683W andpol II holoenzyme from the promoter to allow elongation
R722W), which weaken p44/XPD binding. In both XP-D(Thomas and Tyers, 2000).
cells, we observed a defect in RA transactivation, sug-
gesting that altering this interaction does not allow an
How an XPD Defect Could Explain optimal response to hormonal stress. The normal activ-
Some Clinical Features ity of transcription regulation observed in TTD1Br cells
The present study helps to document certain clinical is in agreement with our previous conclusion that TFIIH
features such as growth defects, developmental abnor- concentration is limiting for DNA repair but not for tran-
scription (Vermeulen et al., 2000) and indicates that onlymalities, or the sterility encountered in XPD-deficient
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pARE-CAT, or pGal-Luc) and, as indicated, 100 ng of either emptyalteration of TFIIH architecture alters RA transactivation.
pcDNA or pcDNA-XPD, 100 ng of pcDNA-ER, 500 ng of pSV-ARo,It cannot be excluded however that, under simultaneous
500 ng pSG5-GVP16, 100 ng of either pSG5-RARWT, pSG5-RAR-genotoxic stress and hormonal stimuli, sublimiting
S77A, pSG5-RARS77E, or empty pSG5. In addition, all transfec-
amounts of TFIIH would also result in some transactiva- tion contained 1 g of the -galactosidase expression vector
tion deficiency. Finally, the severity of the basal tran- pCH110 (Invitrogen) as internal standard and up to 10 g of pSK()
scription defect in most XPB-deficient cell lines, due to as a DNA carrier. After 16 hr incubation, cells were treated with
either ethanol, all-trans retinoic acid (t-RA, 108 to 105 M), 108 Mthe essential role of XPB in promoter opening, did not
17-estradiol (E2), or 108 M 5-dihydrotestosterone (DHT) for 24allow us to detect any variation in hormonal-mediated
hr in a medium without red phenol and containing 10% of charcoal-regulation of transcription.
treated FCS.
Our observations point to a link between the alteration Immortalized fibroblasts were transfected with 2 g of pRARE-
of the p44/XPD interaction and the defect of transactiva- Luc and 1g of pCH110 using the Lipofectamine reagent (Gibco)
tion observed in XPD-deficient cells. However, further and subsequently treated with 106 M t-RA in a medium without red
phenol and containing 10% of charcoal-treated FCS.studies will be required to establish a relationship be-
Cells were harvested 48 hr posttransfection. Luciferase assaystween the position of the mutation in XPD, which affects
were measured using a Microlumat LB96P luminometer (EG&G,the affinity of the kinase for nuclear receptors, and the
Berthold, Germany). For CAT assays, cells were lysed in 100 l ofvariation of the expression of the genes that are regu-
15 mM Tris-HCl (pH 8), 60 mM KCl, 15 mM NaCl, 2 mM EDTA, 1
lated by them. mM DTT, and 0.4 mM PMSF and the activity was measured in
As a conclusion, experiments using XPD-deficient the presence of 1 mM acetylCoA and 0.1 Ci 14C-chloramphenicol.
cells underline the mechanism that links the hormonal Luciferase and CAT activities were adjusted with -galactosidase
activities.signal to gene expression. This mechanism requires a
For EGFP fluorescence analysis, HeLa and HD2 cells were platedfully functional TFIIH, which, by phosphorylating the nu-
on LabTekII chambered coverglasses (Nunc) and were cotrans-clear receptor in a ligand-independent manner, confers
fected with 1g of pRARE-EGFP, 100 ng of either pcDNA or pcDNA-ligand-dependent control of the activation of hormonal
XPD, and 1 g of pCH110. After 24 hr incubation with 106 M t-RA,
responsive genes. living cells were observed under UV using an inverted-phase micro-
scope and images were acquired using the CoolSnap software. Cells
Experimental Procedures were then lysed and the -galactosidase activity was measured as
an internal control.
Vectors Construct
Response elements (RE) for retinoic acid (DR5-type: GGTTCAcc
gaaAGTTCA) and estrogen (PAL3-type: TCAGGTCActgTGACCTGA) Immunopurifications
were generated by the hybridization of oligos: 5-ctagggttcaccgaa Immunopurification of TFIIH was performed as described before
agttcac-3 and 5-tcgagtgaactttcggtgaaccctaggtac-3 for RARE; (Coin et al., 1999), except that it was carried out at either low-salt
5-ctttgatcaggtcactgtgactcgac-3 and 5-tcgagtcaggtcacagtgacct (50 mM) or high-salt (400 mM) concentration.
gatcaaaggtac-3 for ERE. REs were then inserted between the KpnI
and XhoI sites of the pGL3-promoter vector (Promega), upstream
In Vivo and In Vitro Phosphorylation of RARof the SV40 promoter and the luciferase reporter gene, giving rise
For in vivo phosphorylation, cells were starved overnight in a phos-to the pRARE-Luc and pERE-Luc reporter constructs.
phate-deprived medium. After 4 hr of incubation in the presenceThe pRARE-EGFP reporter was constructed by the replacement
of the Luc gene of pRARE-Luc by the gene encoding the enhanced of 250 Ci/ml of [32P]orthophosphate (25 mCi/ml, ICN), cells were
green fluorescent protein (EGFP) (NcoI-XbaI fragment of pEGFP, harvested in ice-cold PBS and lysed in RIPA buffer (10 mM Tris-
Clontech). The pSG5-RARS77E expression plasmid was con- HCl [pH 7.5], 120 mM NaCl, 1% NP40, 1% deoxycholate, and 0.1%
structed as described for pSG5-RARS77A in Rochette-Egly et al. SDS). RAR was then immunoprecipitated at 4C with the mono-
(1997). The pARE-CAT reporter plasmid (named pG29G-tk-CAT in clonal antibody Ab9(F) (Gaub et al., 1992). After washing with
Schule et al., 1988) contains the chloramphenicol acetyl-transferase TG10EK150 (20 mM Tris-HCl [pH 7.9], 10% glycerol, 0.5 mM EDTA,
(CAT) reporter gene under the control of SV40 promoter and two and 150 mM KCl), the immunoprecipitated proteins were resolved
PAL3-type androgen response elements (ARE) spaced by 29 nucleo- by SDS-PAGE, autoradiographed, and immunoblotted with the poly-
tides. The pGal-Luc vector (also named pGL3-Prom-GTG-GAL) con- clonal antibody RP(F)(Gaub et al., 1992).
tains four binding sites for Gal4-VP16 in the XbaI site of pGL3- In vitro phosphorylation of RARa by Hela- or HD2-TFIIH was
Promoter (P. Frit et al., submitted). performed as described in Rochette-Egly et al. (1995). RAR was
analyzed by Western blotting with either RP(F) or a monoclonal
Cell Lines antibody specific for RAR phosphorylated at position S77 (RAR-P-
The primary TTD1VI fibroblasts, assigned to TTD, contain several S77).
alterations in the xpd gene: a L461V transversion and the 716-730
deletion in the C-ter in allele 1 and a R722W substitution in allele 2
(Takayama et al., 1996). The SV40-transformed XP6BE fibroblasts Acknowledgments
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